Meningitis outbreak divides medical groups; associations head to court on corporate disclosure. The fungal meningitis outbreak linked to contaminated shots from a Massachusetts compounding pharmacy has led to some calls for better regulation of the industry, but at least one group is labeling such calls a “witchhunt.” The International Academy of Compounding Pharmacies has responded to the outbreak—which has killed at least 20 people nationwide—mainly through an online Q&A for the public and by regularly updating its members with latest news on the situation. The American Society for Dermatologic Surgery said regulators should “re-examine” oversight of compounding… Read More